• KAFM
  • Contact us
  • E-Submission
ABOUT
ARTICLE CATEGORY
BROWSE ARTICLES
AUTHOR INFORMATION

Page Path

4
results for

"Proteinuria"

Filter

Article category

Keywords

Publication year

Authors

"Proteinuria"

Original Articles
Association between Sarcopenia and Dipstick Proteinuria in the Elderly Population: The Korea National Health and Nutrition Examination Surveys 2009–2011
Duna Hwang, Mi-Ryung Cho, Minyong Choi, Sang Hyun Lee, Youngmin Park
Korean J Fam Med 2017;38(6):372-379.   Published online November 14, 2017
DOI: https://doi.org/10.4082/kjfm.2017.38.6.372
Background

Sarcopenia and proteinuria are significant health difficulties in the elderly; however, few studies have investigated their relationship. In this study, we investigated the association between sarcopenia and proteinuria in Korean subjects over 60 years old.

Methods

We included data from the Korean National Health and Nutrition Examination Survey, a cross-sectional, nationally representative survey conducted from 2009 to 2011 (n=4,008). Sarcopenia was defined using appendicular skeletal muscle mass as a percentage of body weight. Proteinuria was defined by a urine dipstick test result above trace levels.

Results

The overall proteinuria prevalence was 7.2%. The incidence of sarcopenia was significantly higher in subjects with proteinuria. The prevalence of proteinuria was significantly higher in the sarcopenic group (5.5% vs. 14.5% in the non-chronic kidney disease (CKD) group; 17.2% vs. 23.2% in the CKD group) than in the non-sarcopenic group. Furthermore, sarcopenic participants had worse metabolic parameters, such as higher body mass indexes, waist circumferences, and fasting glucose levels, and lower high-density lipoprotein cholesterol levels than those in the non-CKD group. After adjustment for confounders, the odds ratios (95% confidence interval) for proteinuria were 2.84 (1.92–4.18) in the sarcopenic non-CKD group, 3.70 (2.59–5.30) in the non-sarcopenic CKD group, and 5.19 (2.64–10.18) in the sarcopenic CKD group, compared to the non-sarcopenic, non-CKD group. Sarcopenia increased the proteinuria risk in elderly participants without CKD, even after adjustment for obesity, hypertension, diabetes, and metabolic syndrome.

Conclusion

These findings showed that sarcopenia was associated with dipstick proteinuria, especially in elderly participants without CKD, regardless of comorbidities.

Citations

Citations to this article as recorded by  
  • Effect of diabetic kidney disease on sarcopenia and quality of life in patients with type 1 diabetes
    Osman Onur Daloglu, Pinar Uzgec Guller, Zehra Yagmur Sahin Alak, Metin Guclu, Sinem Kiyici
    Endocrine.2025;[Epub]     CrossRef
  • Association between grip strength and albuminuria in the general United States population: NHANES 2011–2014
    Laisha Yan, Xiaoyan Hu, Shanshan Wu, Lina Chen, Shunying Zhao
    Frontiers in Public Health.2024;[Epub]     CrossRef
  • The Relationship Between Sarcopenia And Proteinuria, What Do We Know?
    Ozkan Gungor, Sena Ulu, Ayca Inci, Kenan Topal, Kamyar Kalantar-Zadeh
    Current Aging Science.2024; 17(2): 93.     CrossRef
  • Campanha de prevenção de doença renal crônica: relação entre proteinúria e idosos
    Júlio César Chaves Nunes Filho, David Silva Camurça, Gabriel Alves Rocha, Ana Beatriz Timbó de Oliveira, Gabriela Correia Pequeno Marinho, Sérgio Gabriel Monteiro Santos, Dyego Castelo Branco Holanda Gadelha Pereira, Gdayllon Cavalcante Meneses, Elizabeth
    Brazilian Journal of Nephrology.2023; 45(2): 162.     CrossRef
  • Chronic kidney disease prevention campaign: relationship between proteinuria and elderly people
    Júlio César Chaves Nunes Filho, David Silva Camurça, Gabriel Alves Rocha, Ana Beatriz Timbó de Oliveira, Gabriela Correia Pequeno Marinho, Sérgio Gabriel Monteiro Santos, Dyego Castelo Branco Holanda Gadelha Pereira, Gdayllon Cavalcante Meneses, Elizabeth
    Brazilian Journal of Nephrology.2023; 45(2): 162.     CrossRef
  • Association of Hand Grip Strength and Albuminuria in Adults Aged over 40 Years: The 2019 Korea National Health and Nutrition Examination Survey (KNHANES VIII-1)
    Hae Hyeong Kang, Yohwan Yeo, Jung Jin Cho, Jong Lull Yoon, Mee Young Kim, Bo Mi Chun, Su Jin Lee
    Korean Journal of Family Practice.2023; 13(2): 80.     CrossRef
  • The risk of Parkinson's disease according to diabetic kidney disease status in a Korean population
    Seung Eun Lee, Juhwan Yoo, Han Seok Choi, Kyungdo Han, Kyoung-Ah Kim
    Parkinsonism & Related Disorders.2022; 100: 13.     CrossRef
  • Low urine pH associated with sarcopenia in the elderly
    Akihiro Saitsu, Yoshitaka Iwazu, Haruka Matsushita, Hirotaka Hayashi, Yumiko Mizuhashi, Kazuhiko Kotani
    Medicine.2021; 100(21): e26114.     CrossRef
  • Mock Urinalysis Demonstration: Making Connections among Acid–Base Chemistry, Redox Reactions, and Healthcare in an Undergraduate Nursing Course
    Angela L. Mahaffey
    Journal of Chemical Education.2020; 97(7): 1976.     CrossRef
  • Relationship between Decreased Estimated Glomerular Filtration Rate and Sarcopenic Obesity among Postmenopausal Women: Korea National Health and Nutrition Examination Survey (2008–2011)
    Changbin Hong, Jae Yong Baek, Ji Won Lee, Ji Hoon Lee, Kayoung Lee, Tae-jin Park, Jinseung Kim
    Korean Journal of Family Medicine.2020; 41(5): 332.     CrossRef
  • Breastfeeding and Sarcopenia in Later Life
    Jungun Lee
    Korean Journal of Family Medicine.2019; 40(3): 133.     CrossRef
  • Association between Sarcopenia and Renal Function in Patients with Diabetes: A Systematic Review and Meta-Analysis
    Satoshi Ida, Ryutaro Kaneko, Kanako Imataka, Kazuya Murata
    Journal of Diabetes Research.2019; 2019: 1.     CrossRef
  • 10,119 View
  • 69 Download
  • 9 Web of Science
  • 12 Crossref
Non-alcoholic Fatty Liver Disease and Chronic Kidney Disease in Koreans Aged 50 Years or Older
Ah-Leum Ahn, Jae-Kyung Choi, Mi-Na Kim, Seun-Ah Kim, Eun-Jung Oh, Hyuk-Jung Kweon, Dong-Yung Cho
Korean J Fam Med 2013;34(3):199-205.   Published online May 24, 2013
DOI: https://doi.org/10.4082/kjfm.2013.34.3.199
Background

Non-alcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD) share common pathogenic mechanisms and many risk factors, and both are linked to an increased risk of cardiovascular diseases. The aim of this study was to assess the association between NAFLD and CKD according to the presence of hypertension and diabetes mellitus in Koreans aged 50 years or older.

Methods

A cross-sectional study of 1,706 subjects who received their routine health examination was conducted between May 2008 and April 2010 at Konkuk University medical center. Biochemical tests for liver and abdominal ultrasonography were performed. CKD was defined as either proteinuria or glomerular filtration rate ≤60 mL/min per 1.73 m2.

Results

Among the 1,706 subjects, There were 545 (31.9%) with non-alcoholic fatty liver disease and 424 (24.9%) with chronic kidney disease. In univariate logistic regression analysis, NAFLD was significantly associated with CKD (odds ratio [OR], 1.69; 95% confidence interval [CI], 1.34 to 2.12). In multivariate logistic regression analysis adjusted for age, sex, current smoking, abdominal obesity, aspartate aminotransferases, alanine aminotransferases, γ-glutamyltransferase, hypertension, diabetes mellitus, hypertriglyceridemia, and low high-density lipoprotein cholesterol, NAFLD was associated with CKD (adjusted OR, 1.68; 95% CI, 1.27 to 2.24). This relationship remained significant after classification according to the presence of hypertension or diabetes mellitus.

Conclusion

NAFLD diagnosed by ultrasonography was significantly associated with CKD in Koreans aged 50 years or older.

Citations

Citations to this article as recorded by  
  • Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosis
    Marc Gurun, Paul Brennan, Sava Handjiev, Aseil Khatib, Damien Leith, John F. Dillon, Christopher J. Byrne, Anna Di Sessa
    PLOS ONE.2024; 19(4): e0299507.     CrossRef
  • Impact of Kiwifruit Consumption on Cholesterol Metabolism in Rat Liver: A Gene Expression Analysis in Induced Hypercholesterolemia
    Abdolvahab Ebrahimpour Gorji, Anna Ciecierska, Hanna Leontowicz, Zahra Roudbari, Tomasz Sadkowski
    Nutrients.2024; 16(23): 3999.     CrossRef
  • Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease Cross Talk
    Jacob Nysather, Eda Kaya, Paul Manka, Prakash Gudsoorkar, Wing-Kin Syn
    Advances in Kidney Disease and Health.2023; 30(4): 315.     CrossRef
  • Influence of Nonalcoholic Fatty Liver Disease on the Occurrence and Severity of Chronic Kidney Disease
    Ziwen Tao, Yueyue Li, Baoquan Cheng, Tao Zhou, Yanjing Gao
    Journal of Clinical and Translational Hepatology.2022; 10(1): 164.     CrossRef
  • Advanced liver fibrosis measured by transient elastography predicts chronic kidney disease development in individuals with non-alcoholic fatty liver disease
    Chan-Young Jung, Geun Woo Ryu, Hyung Woo Kim, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
    Diabetologia.2022; 65(3): 518.     CrossRef
  • Therapeutic implications of shared mechanisms in non-alcoholic fatty liver disease and chronic kidney disease
    Mehmet Kanbay, Mustafa C. Bulbul, Sidar Copur, Baris Afsar, Alan A. Sag, Dimitrie Siriopol, Masanari Kuwabara, Silvia Badarau, Adrian Covic, Alberto Ortiz
    Journal of Nephrology.2021; 34(3): 649.     CrossRef
  • Beneficial Effects of Tamarind Trypsin Inhibitor in Chitosan–Whey Protein Nanoparticles on Hepatic Injury Induced High Glycemic Index Diet: A Preclinical Study
    Ana J. F. C. Aguiar, Jaluza L. C. de Queiroz, Pedro P. A. Santos, Christina S. Camillo, Alexandre C. Serquiz, Izael S. Costa, Gerciane S. Oliveira, Ana F. T. Gomes, Lídia L. R. Matias, Rafael O. A. Costa, Thaís S. Passos, Ana H. A. Morais
    International Journal of Molecular Sciences.2021; 22(18): 9968.     CrossRef
  • Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?
    Stefania Kiapidou, Christina Liava, Maria Kalogirou, Evangelos Akriviadis, Emmanouil Sinakos
    Annals of Hepatology.2020; 19(2): 134.     CrossRef
  • Association of nonalcoholic fatty liver and chronic kidney disease: An analysis of 37,825 cases from health checkup center in Taiwan
    Hao-Wen Liu, Jia-Sin Liu, Ko-Lin Kuo
    Tzu Chi Medical Journal.2020; 32(1): 65.     CrossRef
  • NAFLD as a driver of chronic kidney disease
    Christopher D. Byrne, Giovanni Targher
    Journal of Hepatology.2020; 72(4): 785.     CrossRef
  • Correlation Between Non-Alcoholic Fatty Liver and Chronic Kidney Disease
    Hasyim Kasim, St. Rabiul Zatalia, Haerani Rasyid, Syakib Bakri, Muhammad L. Parewangi, Fardah Akil, Arifin Seweng
    The Open Urology & Nephrology Journal.2020; 13(1): 1.     CrossRef
  • Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease
    Andrew A. Li, Aijaz Ahmed, Donghee Kim
    Gut and Liver.2020; 14(2): 168.     CrossRef
  • Risk of Kidney Dysfunction IN Nafld
    Alessandro Mantovani, Chiara Zusi, Andrea Dalbeni, Giorgio Grani, Elena Buzzetti
    Current Pharmaceutical Design.2020; 26(10): 1045.     CrossRef
  • Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease
    Rajkumar Chinnadurai, James Ritchie, Darren Green, Philip A Kalra
    Nephrology Dialysis Transplantation.2019; 34(3): 449.     CrossRef
  • Relations of liver fat with prevalent and incident chronic kidney disease in the Framingham Heart Study: A secondary analysis
    Robert M. Wilechansky, Alison Pedley, Joseph M. Massaro, Udo Hoffmann, Emelia J. Benjamin, Michelle T. Long
    Liver International.2019; 39(8): 1535.     CrossRef
  • Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity‐matched cohort study
    Haesuk Park, Ghadeer K. Dawwas, Xinyue Liu, Mindie H. Nguyen
    Journal of Internal Medicine.2019; 286(6): 711.     CrossRef
  • Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases
    Leon A Adams, Quentin M Anstee, Herbert Tilg, Giovanni Targher
    Gut.2017; 66(6): 1138.     CrossRef
  • Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease
    Giovanni Targher, Christopher D. Byrne
    Nature Reviews Nephrology.2017; 13(5): 297.     CrossRef
  • Nonalcoholic fatty liver disease - A multisystem disease?
    Ivana Mikolasevic, Sandra Milic, Tamara Turk Wensveen, Ivana Grgic, Ivan Jakopcic, Davor Stimac, Felix Wensveen, Lidija Orlic
    World Journal of Gastroenterology.2016; 22(43): 9488.     CrossRef
  • NAFLD: A multisystem disease
    Christopher D. Byrne, Giovanni Targher
    Journal of Hepatology.2015; 62(1): S47.     CrossRef
  • Association between non-alcoholic fatty liver disease and chronic kidney disease in population with prediabetes or diabetes
    Yongqiang Li, Shuangshuang Zhu, Bin Li, Xiaofei Shao, Xinyu Liu, Aiqun Liu, Bifang Wu, Ying Zhang, Honglei Wang, Xiaohong Wang, Kangping Deng, Qin Liu, Min Huang, Hongmei Liu, Harry Holthöfer, Hequn Zou
    International Urology and Nephrology.2014; 46(9): 1785.     CrossRef
  • Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension
    Ki-Chul Sung, Sarah H. Wild, Christopher D. Byrne
    Journal of Hepatology.2014; 60(5): 1040.     CrossRef
  • Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
    Giovanni Musso, Roberto Gambino, James H. Tabibian, Mattias Ekstedt, Stergios Kechagias, Masahide Hamaguchi, Rolf Hultcrantz, Hannes Hagström, Seung Kew Yoon, Phunchai Charatcharoenwitthaya, Jacob George, Francisco Barrera, Svanhildur Hafliðadóttir, Einar
    PLoS Medicine.2014; 11(7): e1001680.     CrossRef
  • CKD and Nonalcoholic Fatty Liver Disease
    Giovanni Targher, Michel B. Chonchol, Christopher D. Byrne
    American Journal of Kidney Diseases.2014; 64(4): 638.     CrossRef
  • 5,556 View
  • 41 Download
  • 24 Crossref
Association of Proteinuria with Metabolic Syndrome in Korean Adults.
Myung Ju Oh, Mi Ji Lee, Kee Hyuck Lee, Min Seon Park, Jeong Ah Ko
Korean J Fam Med 2010;31(6):437-443.   Published online June 20, 2010
DOI: https://doi.org/10.4082/kjfm.2010.31.6.437
Background
Proteinuria is a predictor of chronic kidney disease and a common risk factor for cardiovascular disease. Previous studies have reported that a urinary albumin-creatinine ratio and a glomerular filtration rate was related to the metabolic syndrome. However, there have been few studies on association between the metabolic syndrome and proteinuria by the urine dip-stick test. We examined the association between the metabolic syndrome and the proteinuria by the urine dip-stick test. Methods: The subject of this study included 20,075 adults aged more than 18 years old who visited the Health Promotion Center of the Seoul National University Hospital from April 2001 to March 2007. The metabolic syndrome was defined according to the criteria of the American Heart Association and National Heart, Lung and Blood Institute, and proteinuria was defined as a dipstick test above the '1+' level. The crude and multivariated-adjusted odds ratios of proteinuria were calculated by using logistic regression models with each component of the metabolic syndrome.Results: Proteinuria was noticed in 5.7% of the subjects with metabolic syndrome, and 2.7% without metabolic syndrome. The multivariate-adjusted odds ratios of proteinuria in participants with elevated blood pressure level, elevated plasma glucose level and high triglyceride level were 2.23 (95% confidence interval [CI], 1.95 to 2.55), 2.33 (95% CI, 2.06 to 2.62), 1.64 (95% CI, 1.45 to 1.84). The multivariate-adjusted odds ratio of proteinuria in participants with the metabolic syndrome compared with participants without the metabolic syndrome was 2.30 (95% CI, 1.91 to 2.76), respectively.Conclusion: These findings suggest that proteinuria by the urine dip-stick test might be an important predictor in the metabolic syndrome.

Citations

Citations to this article as recorded by  
  • Analysis of the relationship between components of metabolic syndrome and estimated glomerular filtration rate (eGFR)
    Yoonjin Park
    Heliyon.2025; 11(4): e42591.     CrossRef
  • Mineral Balance and Metabolic Syndrome in Adolescents: Focus on Calcium and Phosphorus Intake
    Yoonjin Park, Jungjin Han
    Healthcare.2021; 9(11): 1525.     CrossRef
  • 3,817 View
  • 21 Download
  • 2 Crossref
The Prevalence of Hematuria and Proteinuria in School Children in Seoul.
Min Chang Cho, Jung Wan Kim, Yun Hee Kim, Ho Lee, Yun Ju Kang, Mee Young Kim, Jong Lull Yoon
J Korean Acad Fam Med 2006;27(3):170-174.   Published online March 10, 2006
Background
: Since 1998, mass urinary screening tests have been conducted in Korean school children. We analyzed the urinary screening test data gathered from the metropolitan city, Seoul, to identify the prevalence of persistent urine abnormalities.

Methods : The students were tested for hematuria and/or proteinuria using dipstick urinalysis. If the results were positive, the students were asked to visit a medical clinic to recheck urinalysis and in report their results.

Results : Among 1,337,210 students, who were screened with initial urinalysis, 10,871 students (proteinuria, 3,626 (0.27%); hematuria, 7,634 (0.57%); both, 389) were recommended to undergo second urinalysis in which 8,819 students (81.1%) did. Among them, 851 had persistent proteinuria and 2,618 had persistent hematuria. The results of the first urinalysis were scored based on the severity of hematuria and proteinuria from +1 to +4. Among all students 24.7% of the students who scored +1 and 40.4% who scored +3 proteinuria on the first test had persistent proteinuria, and 56.4% with both proteinuria and hematuria had persistent proteinuria on the second test. For hematuria, the more positive in the first test showed more prevalence of persistent hematuria. And 61.6% of students with both proteinuria and hematuria had persistent hematuria on the second test.

Conclusion : The presence of both hematuria and proteinuria seemed to be a powerful predictor for persistent abnormal urine finding. And the more positive response in the first test was related to persistent abnormal finding. Therefore we should follow up closely for those students with positive findings.
  • 1,669 View
  • 15 Download
TOP